AusCann Group Holdings Ltd (ACNNF)
AusCann Group Holdings Ltd operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in West Perth, WA, AU. The stock last traded at $0.00, down 15.56% on the session, giving a market capitalisation of $1.7M. On trailing twelve-month figures it carries a trailing P/E of -1.63, a net margin of -977.1%. Its beta of 0.77 implies it has historically moved less than the broad market.
AusCann Group Holdings Ltd currently has no significant operational activities. Historically, the company was dedicated to the research, development, and commercialization of diverse therapeutic products originating from cannabinoids. Its corporate headquarters are located in West Perth, Australia.
AusCann Group Holdings Ltd is most often compared with the following Healthcare names: